James Edward Hinrichs, | |
516 Delaware St Se, Minneapolis, MN 55455-0356 | |
(612) 626-3533 | |
Not Available |
Full Name | James Edward Hinrichs |
---|---|
Gender | Male |
Speciality | Dentist - Periodontics |
Location | 516 Delaware St Se, Minneapolis, Minnesota |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033282603 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223P0300X | Dentist - Periodontics | D08901 (Minnesota) | Primary |
Mailing Address | Practice Location Address |
---|---|
James Edward Hinrichs, 515 Delaware St Se, School Of Dentistry Faculty Practice Clinic, Minneapolis, MN 55455-0357 Ph: () - | James Edward Hinrichs, 516 Delaware St Se, Minneapolis, MN 55455-0356 Ph: (612) 626-3533 |
News Archive
Proteolix, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to carfilzomib, a selective blocker of proteasome activity for the treatment of multiple myeloma.
BioMarin Pharmaceutical Inc. announced today that it has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for BMN-701, a novel fusion of insulin-like growth factor 2 and alpha glucosidase (IGF2-GAA) in development for the treatment of Pompe disease. An investigational new drug application (IND) for BMN-701 has been submitted, investigational material has been manufactured and a Phase I/II study is expected to start in the first quarter of 2011.
Most older gay and bisexual men enrolled in a long-term study of HIV used recreational drugs infrequently over a 10-year period, report University of Pittsburgh Graduate School of Public Health researchers at the XVIII International AIDS Conference.
A new study in JAMA Ophthalmology details plans by University of Michigan Kellogg Eye Center to help curb the nation's opioid epidemic – starting at their own clinic.
Boehringer Ingelheim is a group of companies dedicated to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. It is one of the world's 20 leading pharmaceutical companies. Boehringer Ingelheim's business areas include Prescription Medicines, Consumer Health Care and Biopharmaceuticals, as well as Pharma Chemicals and Animal Health.
› Verified 5 days ago
Dr. Brian J Chase, DMD Dentist Medicare: Medicare Enrolled Practice Location: 515 Delaware St Se, Minneapolis, MN 55455 Phone: 617-895-7348 | |
Dr. Jennifer Lynn Bonamici, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 515 Delaware St Se, Minneapolis, MN 55455 Phone: 612-625-5000 | |
Joanna Christine Bourain, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1313 Penn Ave N, Minneapolis, MN 55411 Phone: 805-729-0090 | |
Dr. Michael W. Lehnert, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 515 Delaware St Se, 7th Floor, Mmhst, Minneapolis, MN 55455 Phone: 612-624-7133 Fax: 612-624-2669 | |
Luke Mcmahon, DDS Dentist Medicare: Accepting Medicare Assignments Practice Location: 606 24th Ave S, Minneapolis, MN 55454 Phone: 612-659-8689 | |
Dr. Brett Andrew Voegele, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 515 Delaware St Se, 7th Floor, Moos Tower, Minneapolis, MN 55455 Phone: 612-624-8600 | |
Julio Sotillo Rodriguez, D.D.S., PH.D. Dentist Medicare: Medicare Enrolled Practice Location: 701 25th Ave S, Suite 400, Minneapolis, MN 55454 Phone: 612-625-3249 |